Your browser doesn't support javascript.
loading
Comparison of dual mTORC1/2 inhibitor AZD8055 and mTORC1 inhibitor rapamycin on the metabolism of breast cancer cells using proton nuclear magnetic resonance spectroscopy metabolomics.
Ni, Zhitao; Xu, Shaolin; Yu, Zheng; Ye, Zhongjiang; Li, Rongqi; Chen, Chuang; Yang, Jianhui; Liu, Huamin; Zhou, Ziye; Zhang, Xiuhua.
Afiliação
  • Ni Z; Clinical Research Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Xu S; Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Yu Z; Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Ye Z; Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Li R; Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Chen C; Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Yang J; Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Liu H; College of Pharmacy, Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Zhou Z; Clinical Research Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. redd88@163.com.
  • Zhang X; Clinical Research Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. Wzzhangxiuhua@126.com.
Invest New Drugs ; 40(6): 1206-1215, 2022 12.
Article em En | MEDLINE | ID: mdl-36063263

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Sirolimo Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Invest New Drugs Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Sirolimo Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Invest New Drugs Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China